Taxpayers Protection Alliance (TPA) released a report on the Food and Drug Administration (FDA)’s Drug Approval Process. Drug approvals are at their lowest since 2016 as developers spend $2 billion and roughly a decade to get a single product approved. TPA’s report addresses these shortcomings and provides evidence-based recommendations for reform.
Despite Taylor Swift’s massive popularity, antitrust action to save her tour hardly qualifies as a pressing public policy priority.
The Supreme Court will hear arguments in Gonzalez v. Google, a case that has the potential to upend the internet for many years. In late 2015, a 23 year-old American named Nohemi Gonzalez tragically lost her life in a terrorist attack carried out by the Islamic State of Iraq and Syria (ISIS).
The Taxpayers Protection Alliance (TPA), a nonprofit, nonpartisan taxpayer and consumer advocacy organization, calls for the Supreme Court to uphold the current interpretation of the law known as Section 230. The Court will hear two cases pertaining to the law in the coming days, Gonzalez v. Google and Twitter v. Taamneh.
Billions of people worldwide benefit from access to safe, effective drugs that often originate and are approved in the U.S. Sadly, many of these medications have come at a terrible cost. About 50 million animals, ranging from rodents and monkeys to cats and dogs, are used by American researchers in experiments each year. This often-cruel practice has been pushed by the Food and Drug Administration (FDA), which until now has mandated animal testing for new drugs.
While addressing youth use of age-restricted products is laudable, lawmakers must refrain from prohibitionist bans on both products that adults responsibly consume and on products that may help adults quit smoking. Youth use of traditional tobacco products has reached record lows, while youth vaping has halved in recent years. Bans will only force adult consumers to seek out illicit products from clandestine sources, which may cause more harm.
While addressing youth use of age-restricted products is laudable, lawmakers must refrain from prohibitionist bans on both products that adults responsibly consume and on products that may help adults quit smoking. Youth use of traditional tobacco products has reached record lows, while youth vaping has halved in recent years. Bans will only force adult consumers to seek out illicit products from clandestine sources, which may cause more harm.
Today, TPA sent a letter to Senate Finance Committee with questions for IRS Commissioner nominee, Daniel Werfel.
Youth use of traditional tobacco products has reached record lows, while youth vaping has halved in recent years. Bans will force adult consumers to seek out illicit products from clandestine sources, which may cause more harm.
While addressing youth use of age-restricted products is laudable, lawmakers must refrain from imposing excise taxes on alternatives to the most dangerous form of tobacco, combustible cigarettes. E-cigarettes are significantly less harmful and their use should be encouraged, not taxed. An excise tax will only deter their use among adults who are unable and/or unwilling to quit smoking.
